Equitec Proprietary Markets’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Equitec Proprietary Markets’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-103,000	Closed	-$274K	–	109
2024 Q1	$274K	Buy	+103,000	New	+$255K	0.17%	34

Equitec Proprietary Markets's KNTE Position: Q2 2024 in Review

Equitec Proprietary Markets sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 103,000 shares — an estimated $274K sold.

Equitec Proprietary Markets first reported a position in KNTE in Q1 2024 and held it in 1 quarter. The position peaked at $274K in Q1 2024. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

Equitec Proprietary Markets reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Equitec Proprietary Markets sold 103,000 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $274K.
Equitec Proprietary Markets first reported a position in Kinnate Biopharma Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Equitec Proprietary Markets's Kinnate Biopharma Inc. Common Stock position peaked at $274K in Q1 2024.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Equitec Proprietary Markets's 13F filing for Q2 2024, filed 12 Jul 2024.